(19)
(11) EP 1 223 987 A2

(12)

(88) Date of publication A3:
04.04.2002

(43) Date of publication:
24.07.2002 Bulletin 2002/30

(21) Application number: 00981226.4

(22) Date of filing: 27.10.2000
(51) International Patent Classification (IPC)7A61K 47/48, A61K 49/00
(86) International application number:
PCT/EP0010/733
(87) International publication number:
WO 0130/390 (03.05.2001 Gazette 2001/18)
(84) Designated Contracting States:
AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE
Designated Extension States:
AL LT LV MK RO SI

(30) Priority: 28.10.1999 GB 9925559

(71) Applicant: SMITHKLINE BEECHAM BIOLOGICALS (S.A.),formerly SMITHKLINE BIOLOGICALS (S.A.)
1330 Rixensart (BE)

(72) Inventors:
  • LAFERRIERE,Craig,Antony,JosephSmithKline Beecham
    B-1330 Rixensart (BE)
  • POOLMAN, JanSmithKline Beecham Biologicals S.A.
    B-1330 Rixensart (BE)
  • SLAOUI,Moncef,MohamedSmithKline Beecham Biologic.
    B-1330 Rixensart (BE)

(74) Representative: Lubienski, Michael John et al
GlaxoSmithKline,Corporate Intellectual Property,CN925.1,980 Great West Road
Brentford,Middlesex TW8 9GS
Brentford,Middlesex TW8 9GS (GB)

   


(54) METHOD